23andMe GHR test
-
FDA Green-Lights Selling of 23andMe's First-Ever Home Genetic Testing Kit
The U.S. Food and Drug Administration (FDA) announced on Thursday that it will allow the marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests to give consumers information regarding their risk to certain diseases.
Latest Research Articles
most popular
-
World’s Largest Organism May Have Persisted Since the First Human Migrations
-
World’s Biggest Coral, Hidden Beneath Solomon Islands Waters, Revealed by Diver
-
Monkeypox Evolution Reaches Deadly Strain, Now Detected in US
-
Mauna Loa’s Lava Study Confirms Geologists’ Early Warning of Eruption
-
Global Plastic Pileup Could Be Halted With Four Policies, California Study Finds
